VAV2: a novel prognostic marker and a druggable target for adrenocortical carcinoma.

Oncotarget · 2017 · PMC5687602 · PMID 29179432

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A remarkable clinically relevant outcome of our study consists in the highly significant correlation between high VAV2 abundance and reduced ACC patient survival [ 4 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.